<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

Neurite Outgrowth Assay

 

Assessment Of Compounds For Spinal Cord Injury and Neurodegeneration

 

Neurite outgrowth is the projection and extension of neural processes from developing neuronal cell bodies that occurs via cytoskeletal reorganization, and is an important process during normal neuronal development. Through this process, neurons organize themselves into highly complex, functional networks connected synaptically to one another. Modulation of this neurite outgrowth process (neuritogenesis) has been implicated in a wide range of CNS diseases, including neurodegenerative disorders such as Parkinson’s Disease and stroke, as well as spinal cord injuries and various forms of neurotoxicity. Developing a detailed understanding of this process is an important focus of active neuroscientific research, and MD Biosciences has a validated a neurite outgrowth assay for assessment of potential therapeutic compounds in these disease areas.

The neurite outgrowth assay provides an in vitro method to examine the potential effects of exogenous compounds on neuronal activity and development, providing valuable information on the potential of therapeutic compounds to either enhance or inhibit neuritogenesis.

 Primary cells are dissociated directly from adult (>5 weeks old) rat spinal cord tissue, plated in media and incubated with test items or controls. Cells are then monitored longitudinally, stained using immunocytochemistry against cytoskeletal antigens (Tubulin III) and neurites are quantified for length.

Example data

Kinetics of Adult Neurite Growth In Culture

neurite-outgrowth-assay-mdbiosciences

neurite outgrowth assay-mdbiosciences

neurite outgrowth assay-md biosciences

 

 

READY TO DISCUSS YOUR PROGRAM?

If you are ready to discuss how a partnership can fit into your development program, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can rely on predictive preclinical data.

Request Proposal